DNA Analysis of Blood and Tissue From Patients With Lung Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Nowo rozpoznany pierwotny rak pluca
- •Pacjent Massachusetts General Hospital (MGH) lub Boston Medical Center Cancer Center
✗ Disqualifies
- •Rak, który przerzutował do płuc z innego miejsca w ciele
- •Opleciomięsak (nowotwór otoczki płuc)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 120 Years
- Last updated (source)
- October 7, 2026
- Sex
- No restrictions
Locations (2)
Massachusetts General Hospital
Boston, United States
Harvard School of Public Health
Boston, United States
Trial contact
Clinical Trials Office - Massachusetts General Hospital
David C. Christiani, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.